CytomX Therapeutics Inc.

(CTMX) Trade

By |

Profile

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platform. The company probody technology platform to create proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of unique conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues. The company focuses on developing Probody therapeutics which addresses clinically-validated cancer targets in immuno-oncology that are difficult to drug and lead to concerns about damage to healthy tissues or toxicities.

Contact Information

Website: www.cytomx.com
Email: ckeenan@cytomx.com
Main Phone: +1 650 515-3185
Address: 151 Oyster Point Boulevard
Address 2: Suite 400
State: CA
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: NGS
CEO: Sean A. McCarthy
Employees: 92
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 14.77 $ -0.09 (-0.61%)
Last Price 14.77 Change $ -0.09 Change % -0.61 Tick N/A
Bid 13.05 Bid Size 200.00 Ask 18.58 Ask Size 100.00
Open 15.04 High 15.46 Low 14.60 Prev Close 14.86
Last Trade Volume 380,025 52 Wk Hi 35.00 52 Wk Low 12.51
Market Cap 664.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 45,007,104.00 EPS (TTM) -1.25 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 11 84
Number of Buys 6 34
Number of Sells 5 50
Net Activity -3511 -1977686
Last 10 Buys Shares
Flynn E James 1,000
Flynn E James 1,000
Cynthia Ladd 1,000
W. Michael Kavanaugh 1,000
Frederick W. Gluck 1,000
Frederick W. Gluck 1,000
Last 10 Sell Shares
Debanjan Ray 1,000
Debanjan Ray 1,000
Sean A. McCarthy 1,000
Debanjan Ray 1,000
Frederick W. Gluck 1,000
Debanjan Ray 1,000
Debanjan Ray 1,000
Rachel Humphrey 1,000
Frederick W. Gluck 1,000
Debanjan Ray 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 40 40 40 40
Low Target Price Estimate 37 37 37 37
Mean Target Price Estimate 39 39.2 39.2 39
Standard Deviation 1.26 1.3 1.3 1.26
Date of Most Recent Estimate 06/05/18 05/22/18 05/22/18 06/05/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 6 6 6
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.25 1.29 1.29 1.29